Response to: Mortality rate of bullous pemphigoid in a US medical center [2]

Journal of Investigative Dermatology

Volumn 124, Issue 3, 2005, Pages 664-665

  Joly, Pascal ^a,e   Benichou, Jacques ^a   Saiag, Philippe ^b   Bernard, Philippe ^c   Roujeaul, Jean Claude ^d  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CENTER; HOSPITALIZATION; HUMAN; LETTER; MORTALITY; PEMPHIGOID; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES;

EID: 15044338658     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23626.x     Document Type: Letter

References (7)

1. Bernard P, Bedane C, Bonnetblanc JM: Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: A cohort analysis of 94 elderly patients. Br J Dermatol 136:694-698, 1997
2. Colbert RL, Allen DM, Eastwood D, Fairley JA: Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 122:1091-1095, 2004
3. Joly P, Roujeau JC, Benichou J, et al: A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346:321-327, 2002
4. Joly P, Roujeau JC, Benichou J, et al: Prediction of survival for patients with bullous pemphigoid. Arch Dermatol 2005, in press
5. Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P: High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134:465-469, 1998
6. Rzany B, Partscht K, Jung M, et al: Risk factors for lethal outcome in patients with bullous pemphigoid. Arch Dermatol 138:903-908, 2002
7. Swerlick RA, Korman NJ: Bullous pemphigoid: What is the prognosis? (Editorial). J Invest Dermatol 122:1091-1092, 2004